{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T20:33:26Z","timestamp":1768595606501,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.humpath.2025.106008","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:16:54Z","timestamp":1764951414000},"page":"106008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantitative assessment of cribriform intraductal carcinoma of the prostate is useful for risk stratification after radical prostatectomy"],"prefix":"10.1016","volume":"167","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7610-7769","authenticated-orcid":false,"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.106008_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2025.106008_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of indicende and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2025.106008_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bju.14237","article-title":"Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer","volume":"122","author":"Lancee","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2025.106008_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European association of urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.humpath.2025.106008_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.106008_bib6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib7","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.106008_bib8","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2025.106008_bib10","series-title":"Urinary and male genital tumours","first-page":"200","year":"2022"},{"key":"10.1016\/j.humpath.2025.106008_bib11","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/cancers15225319","article-title":"Intraductal carcinoma of the prostate: to grade or not to grade","volume":"15","author":"Surintrspanont","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2025.106008_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.eururo.2014.09.006","article-title":"Tracking the origin of metastatic prostate cancer","volume":"67","author":"Linberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2025.106008_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/bju.14043","article-title":"Intraductal carcinoma of the prostate can evade andsrogen deprivation, with emergence of castrate-tolerant cells","volume":"121","author":"Porter","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2025.106008_bib14","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41585-018-0013-1","article-title":"Historical and contemporary perspectives on cribriform morphology in prostate cancer","volume":"15","author":"Truong","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.humpath.2025.106008_bib15","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.1016\/j.eururo.2021.06.001","article-title":"Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy","volume":"80","author":"Cimadamore","year":"2021","journal-title":"Eur Urol. In press"},{"key":"10.1016\/j.humpath.2025.106008_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathol.2024.08.012","article-title":"Cribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional\/acinar prostatic adenocarcinoma","volume":"57","author":"Wang","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2025.106008_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.humpath.2023.06.011","article-title":"Comedonecrosis within conventional prostatic adenocarcinoma vs. intraductal carcinoma of the prostate: their clinical significance is not comparable","volume":"138","author":"Wang","year":"2023","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5858\/arpa.2021-0346-OA","article-title":"The clinical impact of comedonecrosis within intraductal carcinoma of the prostate","volume":"147","author":"Wang","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2025.106008_bib19","article-title":"Intraductal carcinoma of the prostate with a solid nest pattern may be more aggressive than Gleason grade 5 conventional prostatic adenocarcinoma","author":"Shi","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100429","article-title":"Prostate cancer risk stratification by simple scoring of the current pT3 lesions: a proposal for a new pathologic T-staging system","volume":"37","author":"Miyamoto","year":"2024","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib21","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 5S","key":"10.1016\/j.humpath.2025.106008_bib22","first-page":"e302","article-title":"Cribriform intraductal carcinoma of the prostate might even be more aggressive than Gleason grade 5 conventional prostatic adenocarcinoma","volume":"213","author":"Wang","year":"2025","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.106008_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PAS.0b013e3181cfc44b","article-title":"Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies","volume":"34","author":"Shah","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2025.105841","article-title":"Atypical intraductal proliferation (AIP) of the prostate: findings in repeat biopsy or radical prostatectomy in patients who met pathologic criteria for active surveillance","volume":"160","author":"Lin","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib25","article-title":"The Genitourinary Pathology society and International society of urological pathology joint expert consultation recommendations on intraductal carcinoma of the prostate","author":"Shah","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106008_bib26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical recurrence following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.humpath.2025.106008_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2025.106008_bib28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41379-022-01009-7","article-title":"Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for \u201clarge\u201d cribriform prostatic adenocarcinoma","volume":"35","author":"Chan","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41391-022-00600-y","article-title":"Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis","volume":"26","author":"Russo","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2025.106008_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/his.15102","article-title":"Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with grade group 2 prostate cancer","volume":"84","author":"Greenland","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106008_bib31","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/ajcp\/aqae082","article-title":"Prognostic significance of invasive cribriform gland size and percentage in gleason score 7 prostate adenocarcinoma","volume":"162","author":"Tekin","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2021.09.005","article-title":"Prognostic value of cribriform size, percentage, and intraductal carcinoma in gleason score 7 prostate cancer with cribriform gleason pattern 4","volume":"118","author":"Chen","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.21873\/cdp.10386","article-title":"Cribriform pattern is a predictive factor of PSA recurrence in patients receiving radiotherapy after prostatectomy","volume":"4","author":"Kawahara","year":"2024","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.humpath.2025.106008_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7086","article-title":"Significance of the cribriform morphology area ration for biochemical recurrence in gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy","volume":"13","author":"Shimodaira","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.humpath.2025.106008_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/PAP.0000000000000303","article-title":"Intraductal carcinoma of the prostate: a guide for the practicing pathologist","volume":"28","author":"Varma","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.anndiagpath.2014.08.010","article-title":"Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists","volume":"18","author":"Iczkowski","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2025.106008_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00428-020-02902-9","article-title":"Inter-observer variability of cribriform architecture and percent gleason pattern 4 in prostate cancer: relation to clinical outcome","volume":"478","author":"van der Slot","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.106008_bib39","first-page":"3990","article-title":"Diagnosis of \u201ccribriform\u201d prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations","volume":"11","author":"Shah","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.humpath.2025.106008_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/his.14132","article-title":"Grading of prostate cancer: the impact of including intraductal carcinoma on the overall grade group assigned in diagnostic biopsies","volume":"77","author":"Chen-Maxwell","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106008_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/his.14179","article-title":"Intraductal carcinoma has a minimal impact on grade group assignment in prostate cancer biopsy and radical prostatectomy specimens","volume":"77","author":"Rijstenberg","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.106008_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5858\/arpa.2020-0770-LE","article-title":"Grading intraductal carcinoma in prostate biopsies changes risk categorization in a small subset of cases","volume":"145","author":"Rizzo","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2025.106008_bib43","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3390\/cancers13215454","article-title":"Contemporary grading of prostate cancer: the impact of grading criteria and the significance of the amount of intraductal carcinoma","volume":"13","author":"Tzelepi","year":"2021","journal-title":"Cancers"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:32:42Z","timestamp":1768555962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0046817725002953"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative assessment of cribriform intraductal carcinoma of the prostate is useful for risk stratification after radical prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.106008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106008"}}